Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64630

1.

Targeted Drug-Loaded Chemical Probe Staining Assay to Predict Therapy Response and Function as an Independent Pathological Marker.

Zhang H, Zhong WL, Sun B, Yang G, Liu YR, Zhou BJ, Chen X, Jing XY, Huai LC, Liu N, Zhang ZY, Li MM, Han JX, Qiao KL, Meng J, Zhou HG, Chen S, Yang C, Sun T.

iScience. 2019 Oct 28;21:549-561. doi: 10.1016/j.isci.2019.10.050. [Epub ahead of print]

PMID:
31715498
2.

CA8 promotes RCC proliferation and migration though its expression level is lower in tumor compared to adjacent normal tissue.

Ma HL, Yu SJ, Chen J, Ding XF, Chen G, Liang Y, Pan JL.

Biomed Pharmacother. 2019 Nov 9;121:109578. doi: 10.1016/j.biopha.2019.109578. [Epub ahead of print]

PMID:
31715371
3.

Loss of PTPRJ/DEP-1 enhances NF2/Merlin-dependent meningioma development.

Waldt N, Scharnetzki D, Kesseler C, Kirches E, Stroscher N, Böhmer FD, Mawrin C.

J Neurol Sci. 2019 Nov 9;408:116553. doi: 10.1016/j.jns.2019.116553. [Epub ahead of print]

PMID:
31715329
4.

Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.

Ray D, Ray P, Ferrer-Torres D, Wang Z, Nancarrow D, Yoon HW, San Martinho M, Hinton T, Owens S, Thomas D, Jiang H, Lawrence TS, Lin J, Lagisetty K, Chang AC, Beer DG.

Gastroenterology. 2019 Nov 9. pii: S0016-5085(19)41531-X. doi: 10.1053/j.gastro.2019.10.040. [Epub ahead of print]

PMID:
31715145
5.

A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo.

Bai L, Zhou H, Xu R, Zhao Y, Chinnaswamy K, McEachern D, Chen J, Yang CY, Liu Z, Wang M, Liu L, Jiang H, Wen B, Kumar P, Meagher JL, Sun D, Stuckey JA, Wang S.

Cancer Cell. 2019 Nov 11;36(5):498-511.e17. doi: 10.1016/j.ccell.2019.10.002.

PMID:
31715132
6.

Inhibit versus Destroy: Are PROTAC Degraders the Solution to Targeting STAT3?

Heppler LN, Frank DA.

Cancer Cell. 2019 Nov 11;36(5):459-461. doi: 10.1016/j.ccell.2019.10.010.

PMID:
31715126
7.

NeuroD1 promotes colorectal cancer cell proliferation and tumorigenesis by suppressing p53/p21 axis.

Lei K, Li W, Huang C, Li Y, Alfason L, Zhao H, Miyagishi M, Wu S, Kasim V.

Cancer Sci. 2019 Nov 12. doi: 10.1111/cas.14233. [Epub ahead of print]

PMID:
31715070
8.

Comparison of biological properties of [177 Lu]Lu-ProBOMB1 and [177 Lu]Lu-NeoBOMB1 for GRPR-targeting.

Rousseau E, Lau J, Zhang Z, Zhang C, Kwon D, Uribe CF, Kuo HT, Zeisler J, Bratanovic I, Lin KS, Bénard F.

J Labelled Comp Radiopharm. 2019 Nov 12. doi: 10.1002/jlcr.3815. [Epub ahead of print]

PMID:
31715025
9.

Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.

Iliopoulou BP, Hsu K, Pérez-Cruz M, Tang SW, Pang WW, Erkers T, Kambham N, Freeman GJ, Dekruyff RH, Meyer EH.

Blood Adv. 2019 Nov 12;3(21):3419-3431. doi: 10.1182/bloodadvances.2019000286.

PMID:
31714958
10.

X-Ray Crystal Structure Guided Discovery and Antitumor Efficacy of Dihydroquinoxalinone as Potent Tubulin Polymerization Inhibitors.

Arnst KE, Banerjee S, Wang Y, Chen H, Li Y, Yang L, Li W, Miller DD, Li W.

ACS Chem Biol. 2019 Nov 12. doi: 10.1021/acschembio.9b00696. [Epub ahead of print]

PMID:
31714738
11.

Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models.

Santiago-O'Farrill JM, Weroha SJ, Hou X, Oberg AL, Heinzen EP, Maurer MJ, Pang L, Rask P, Amaravadi RK, Becker SE, Romero I, Rubio MJ, Matias-Guiu X, Santacana M, Llombart-Cussac A, Poveda A, Lu Z, Bast RC Jr.

Cancer. 2019 Nov 12. doi: 10.1002/cncr.32600. [Epub ahead of print]

PMID:
31714594
12.

Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models.

Stefka AT, Johnson D, Rosebeck S, Park JH, Nakamura Y, Jakubowiak AJ.

Cancer Med. 2019 Nov 12. doi: 10.1002/cam4.2695. [Epub ahead of print]

PMID:
31714026
13.

A bright NIR-II fluorescent probe for breast carcinoma imaging and image-guided surgery.

Zeng X, Xie L, Chen D, Li S, Nong J, Wang B, Tang L, Li Q, Li Y, Deng Z, Hong X, Wu M, Xiao Y.

Chem Commun (Camb). 2019 Nov 12. doi: 10.1039/c9cc07694h. [Epub ahead of print]

PMID:
31712798
14.

Long noncoding RNA RBMS3-AS3 acts as a microRNA-4534 sponge to inhibit the progression of prostate cancer by upregulating VASH1.

Jiang Z, Zhang Y, Chen X, Wu P, Chen D.

Gene Ther. 2019 Nov 11. doi: 10.1038/s41434-019-0108-1. [Epub ahead of print]

PMID:
31712637
15.

Long non-coding RNA H19 promotes tumorigenesis of multiple myeloma by activating BRD4 signaling by targeting miR-152-3p.

Zheng JF, Guo NH, Zi FM, Cheng J.

Mol Cell Biol. 2019 Nov 11. pii: MCB.00382-19. doi: 10.1128/MCB.00382-19. [Epub ahead of print]

PMID:
31712391
16.

Osthole delays hepatocarcinogenesis in mice by suppressing AKT/FASN axis and ERK phosphorylation.

Mo Y, Wu Y, Li X, Rao H, Tian X, Wu D, Qiu Z, Zheng G, Hu J.

Eur J Pharmacol. 2019 Nov 8:172788. doi: 10.1016/j.ejphar.2019.172788. [Epub ahead of print]

PMID:
31712058
17.

ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.

Liu M, Zhang Y, Yang J, Cui X, Zhou Z, Zhan H, Ding K, Tian X, Yang Z, Fung KA, Edil BH, Postier RG, Bronze MS, Fernandez-Zapico ME, Stemmler MP, Brabletz T, Li YP, Houchen CW, Li M.

Gastroenterology. 2019 Nov 8. pii: S0016-5085(19)41529-1. doi: 10.1053/j.gastro.2019.10.038. [Epub ahead of print]

PMID:
31711924
18.

miR-34a Enhances the Susceptibility of Gastric Cancer to Platycodin D by Targeting Survivin.

Peng Y, Fan JY, Xiong J, Lou Y, Zhu Y.

Pathobiology. 2019 Nov 11:1-10. doi: 10.1159/000502913. [Epub ahead of print]

PMID:
31711057
19.

Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation.

Lin PH, Tung YT, Chen HY, Chiang YF, Hong HC, Huang KC, Hsu SP, Huang TC, Hsia SM.

J Pineal Res. 2019 Nov 11:e12620. doi: 10.1111/jpi.12620. [Epub ahead of print]

PMID:
31710386
20.

Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis.

Heo J, Noh BJ, Lee S, Lee HY, Kim Y, Lim J, Ju H, Yu HY, Ryu CM, Lee PC, Jeong H, Oh Y, Kim K, Kim SY, Son J, Hong B, Kim JS, Cho YM, Shin DM.

EMBO Mol Med. 2019 Nov 11:e10880. doi: 10.15252/emmm.201910880. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center